A Mel PET scan for melanoma combines a radioactive tracer with positron emission tomography to image metabolic activity in melanoma lesions. This two-part test is commonly used to evaluate suspected advanced disease, monitor response to systemic therapy, and detect recurrence when anatomy alone is inconclusive on CT or MRI. Understanding the strengths, limits, and typical process helps people living with melanoma and their care teams make informed decisions about staging, surveillance, and treatment selection.
What Is a Mel PET Scan and Why It Is Used in Melanoma
Melanoma PET scan refers to positron emission tomography imaging with an injected radioactive tracer, most often 18F-fluorodeoxyglucose (18F-FDG). Cancer cells with high glucose metabolism typically accumulate more tracer than normal tissue, so PET can highlight areas of increased metabolic activity. In melanoma, PET is usually paired with computed tomography (CT) in a single session to fuse metabolic signals with anatomic detail. It is most valuable when CT or MRI findings are uncertain, when staging known advanced disease, or when checking for recurrence after treatment.
How the Two-Part Mel PET Test Is Done
Preparation and Tracer Injection
Preparation often includes fasting for several hours, staying hydrated, and avoiding strenuous exercise for 24 hours before the scan. A small amount of 18F-FDG is injected into a vein. After a waiting period of about 30 to 60 minutes, the body distributes the tracer in proportion to cellular glucose use. Blood sugar levels near normal improve image clarity, so people with diabetes may receive specific guidance.
Scan Procedure and Timing
During the scan, you lie still on a table that moves through a ring-shaped scanner. A typical PET scan takes 20 to 40 minutes. When combined with CT, the entire appointment may last 1 to 2 hours, including preparation and contrast administration if used. You may be asked to change into a gown and remove metal objects that could interfere with the images.
How PET Adds Value to Melanoma Staging and Follow-Up
In melanoma, staging determines how far the disease has spread. For early-stage disease, PET is generally not used because it rarely changes management when tumors are small and confined. It becomes more relevant for locally advanced or stage III disease, where it can identify affected lymph node basins that appear normal on CT or ultrasound, and for stage IV disease to evaluate distant spread to the liver, lungs, bones, or brain. For some people, PET may change the suspected stage, which in turn can alter treatment plans.
Comparing Mel PET to Other Imaging Modalities
- CT and MRI provide detailed anatomy, but they cannot reliably distinguish inactive scar from active melanoma.
- PET highlights metabolic activity, which can suggest melanoma, but it cannot reliably differentiate melanoma from some infections or inflammatory conditions.
- Whole-body PET–CT is often preferred over PET alone because it simultaneously captures anatomy and metabolism in a single exam.
Interpreting Mel PET Results: What the Images Show
Images from a Mel PET scan are reviewed by a nuclear medicine physician and a radiologist. They look for areas where the tracer accumulates more than expected, called focal uptake. These areas may represent melanoma, but further evaluation with biopsy or comparison to prior scans is usually needed to confirm. Reports typically describe the distribution, intensity, and pattern of tracer uptake, and may include a standardized uptake value (SUV) measurement. SUV helps quantify how much tracer a lesion retains, although there are no absolute cutoff values that diagnose melanoma on its own.
Limitations, False Positives, and False Negatives
No imaging test is perfect. Inflammation, infection, or other cancers can cause false-positive findings on PET, leading to unnecessary procedures. Conversely, small lesions, certain tumor types, or low metabolic activity can cause false-negatives, meaning melanoma is present but not visible on PET. For this reason, suspicious findings on PET are often followed by biopsy or contrast-enhanced CT or MRI. Clinical context, tumor biology, and trends over time are important parts of interpretation.
How Results Guide Treatment and Next Steps
If a Mel PET scan suggests advanced melanoma, additional tests may be recommended to confirm the extent of disease before treatment begins. For people receiving systemic therapy, PET can sometimes show early metabolic changes that may precede size-based responses on CT, which can inform decisions about continuing or changing treatment. After successful treatment, PET may be used when recurrence is suspected but not clearly seen on anatomic scans. The results are always considered alongside blood tests, physical findings, and prior scans to build a complete picture.
Practical Considerations and What to Expect
After the Scan
You can usually resume normal activities immediately after the test. Drinking extra fluids helps flush the tracer from your body. If contrast was used during the CT portion, you may be advised to stay hydrated and monitor for any reactions. Results are typically available within a few days, after all images are reviewed and compared with prior studies.
Risks and Safety Notes
- The tracer involves a small amount of radiation, comparable to other nuclear medicine tests.
- Allergic reactions to the tracer or contrast are uncommon but possible.
- Pregnancy and breastfeeding may require special precautions; tell your care team if you are pregnant, planning pregnancy, or breastfeeding.
Key Facts at a Glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Common tracer | 18F-fluorodeoxyglucose (18F-FDG) | Standard nuclear medicine practice |
| Typical wait after injection | 30–60 minutes | Clinical protocols |
| Exam duration | 20–40 minutes for PET, up to 2 hours for PET–CT appointment | Imaging department guidelines |
| Primary strength | Shows areas of high metabolic activity across the body | Radiology literature |
| Key limitation | Cannot reliably distinguish melanoma from some benign inflammatory conditions | Radiology and oncology guidelines |
Questions to Ask Your Care Team
Having clear questions can make follow-up discussions more productive. Consider asking:
- Why is a Mel PET scan being recommended in my situation, and what specific clinical question is it intended to answer?
- How will these results be combined with my blood tests, physical exam, and other scans to determine my stage or treatment plan?
- What are the potential next steps if the PET scan shows areas that might be melanoma, scar, or unclear findings?
Summary
A Mel PET scan is a functional imaging tool used in melanoma to detect areas of abnormal metabolic activity, often combined with CT for anatomic detail. It plays a defined role in evaluating advanced or recurrent disease, particularly when other imaging results are ambiguous. Results must be interpreted in context with clinical findings and other tests. Knowing what to expect before, during, and after the exam can help you prepare and understand how the results may influence your care path.